Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 825

1.

Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry.

Mahendran SM, Keystone EC, Krawetz RJ, Liang K, Diamandis EP, Chandran V.

Clin Proteomics. 2019 May 30;16:23. doi: 10.1186/s12014-019-9243-3. eCollection 2019.

2.

Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses.

Di Paolo CT, Filippou PS, Yu Y, Poda G, Diamandis EP, Prassas I.

Clin Chem Lab Med. 2019 May 27. pii: /j/cclm.ahead-of-print/cclm-2019-0123/cclm-2019-0123.xml. doi: 10.1515/cclm-2019-0123. [Epub ahead of print]

PMID:
31129650
3.

Biochemical pathways mediated by KLK6 protease in breast cancer.

Pampalakis G, Zingkou E, Sidiropoulos KG, Diamandis EP, Zoumpourlis V, Yousef GM, Sotiropoulou G.

Mol Oncol. 2019 Apr 13. doi: 10.1002/1878-0261.12493. [Epub ahead of print]

4.

Benefits and harms of wellness initiatives.

Fiala C, Taher J, Diamandis EP.

Clin Chem Lab Med. 2019 Mar 26. pii: /j/cclm.ahead-of-print/cclm-2019-0122/cclm-2019-0122.xml. doi: 10.1515/cclm-2019-0122. [Epub ahead of print]

PMID:
30913033
5.

Androgen receptor: A promising therapeutic target in breast cancer.

Vasiliou SK, Diamandis EP.

Crit Rev Clin Lab Sci. 2019 May;56(3):200-223. doi: 10.1080/10408363.2019.1575643. Epub 2019 Mar 1.

PMID:
30821186
6.

Cell-free DNA Analysis in Cancer.

Fiala C, Diamandis EP.

N Engl J Med. 2019 Jan 31;380(5):501. doi: 10.1056/NEJMc1816154. No abstract available.

PMID:
30702289
7.

Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.

Dimitrakopoulos L, Prassas I, Sieuwerts AM, Diamandis EP, Martens JWM, Charames GS.

Clin Biochem. 2019 Apr;66:63-75. doi: 10.1016/j.clinbiochem.2019.01.005. Epub 2019 Jan 23.

PMID:
30684468
8.

The democratization of scientific publishing.

Fiala C, Diamandis EP.

BMC Med. 2019 Jan 18;17(1):12. doi: 10.1186/s12916-019-1249-1.

9.

Functional proteomic profiling reveals KLK13 and TMPRSS11D as active proteases in the lower female reproductive tract.

Muytjens CMJ, Yu Y, Diamandis EP.

Version 2. F1000Res. 2018 Oct 19 [revised 2018 Jan 1];7:1666. doi: 10.12688/f1000research.16255.2. eCollection 2018.

10.

The plasma peptides of ovarian cancer.

Dufresne J, Bowden P, Thavarajah T, Florentinus-Mefailoski A, Chen ZZ, Tucholska M, Norzin T, Ho MT, Phan M, Mohamed N, Ravandi A, Stanton E, Slutsky AS, Dos Santos CC, Romaschin A, Marshall JC, Addison C, Malone S, Heyland D, Scheltens P, Killestein J, Teunissen CE, Diamandis EP, Michael Siu KW, Marshall JG.

Clin Proteomics. 2018 Dec 21;15:41. doi: 10.1186/s12014-018-9215-z. eCollection 2018.

11.

Can Grail find the trail to early cancer detection?

Fiala C, Diamandis EP.

Clin Chem Lab Med. 2019 Mar 26;57(4):403-406. doi: 10.1515/cclm-2018-1249. No abstract available.

12.

The plasma peptidome.

Dufresne J, Bowden P, Thavarajah T, Florentinus-Mefailoski A, Chen ZZ, Tucholska M, Norzin T, Ho MT, Phan M, Mohamed N, Ravandi A, Stanton E, Slutsky AS, Dos Santos CC, Romaschin A, Marshall JC, Addison C, Malone S, Heyland D, Scheltens P, Killestein J, Teunissen C, Diamandis EP, Siu KWM, Marshall JG.

Clin Proteomics. 2018 Dec 1;15:39. doi: 10.1186/s12014-018-9211-3. eCollection 2018.

13.

Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974.

Schiza C, Korbakis D, Jarvi K, Diamandis EP, Drabovich AP.

Mol Cell Proteomics. 2019 Feb;18(2):338-351. doi: 10.1074/mcp.RA118.001170. Epub 2018 Nov 14.

14.

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.

Fiala C, Diamandis EP.

BMC Med. 2018 Oct 2;16(1):166. doi: 10.1186/s12916-018-1157-9.

15.

Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers?

Music M, Prassas I, Diamandis EP.

Crit Rev Clin Lab Sci. 2018 Nov;55(7):466-479. doi: 10.1080/10408363.2018.1499706. Epub 2018 Oct 2. Review.

PMID:
30277835
16.

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.

Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.

F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.

17.

The International Society for Enzymology: a glorious history, a golden legacy.

Diamandis EP, Scorilas A, Prassas I, Plebani M.

Clin Chem Lab Med. 2018 Oct 25;56(11):275-276. doi: 10.1515/cclm-2018-0766. No abstract available.

PMID:
30157030
18.

Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.

Schiza C, Korbakis D, Panteleli E, Jarvi K, Drabovich AP, Diamandis EP.

Mol Cell Proteomics. 2018 Dec;17(12):2480-2495. doi: 10.1074/mcp.RA118.000749. Epub 2018 Aug 10.

PMID:
30097533
19.

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics.

Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V.

Version 2. F1000Res. 2018 Feb 14 [revised 2018 Jan 1];7:189. doi: 10.12688/f1000research.13863.2. eCollection 2018.

20.

Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.

Filippou PS, Ren AH, Soosaipillai A, Papaioannou MD, Korbakis D, Safar R, Diamandis EP, Conner JR.

Clin Biochem. 2018 Sep;59:78-85. doi: 10.1016/j.clinbiochem.2018.06.017. Epub 2018 Jun 26.

PMID:
29958881
21.

Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.

Filippou PS, Ren AH, Bala S, Papaioannou MD, Brinc D, Prassas I, Karakosta T, Diamandis EP.

Clin Biochem. 2018 Aug;58:108-115. doi: 10.1016/j.clinbiochem.2018.06.007. Epub 2018 Jun 18.

PMID:
29928903
22.

Towards personalized tumor markers.

Kulasingam V, Prassas I, Diamandis EP.

NPJ Precis Oncol. 2017 May 25;1(1):17. doi: 10.1038/s41698-017-0021-2. eCollection 2017.

23.

Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.

Filippou PS, Ren AH, Korbakis D, Dimitrakopoulos L, Soosaipillai A, Barak V, Frenkel S, Pe'er J, Lotem M, Merims S, Molina R, Blasutig I, Bogdanos DP, Diamandis EP.

Clin Chem Lab Med. 2018 Oct 25;56(11):1945-1953. doi: 10.1515/cclm-2018-0139.

PMID:
29768245
24.

The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry.

Fiala C, Diamandis EP.

Clin Chem Lab Med. 2018 Aug 28;56(9):1443-1446. doi: 10.1515/cclm-2018-0353.

25.

Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications.

Begcevic I, Brinc D, Dukic L, Simundic AM, Zavoreo I, Basic Kes V, Martinez-Morillo E, Batruch I, Drabovich AP, Diamandis EP.

J Proteome Res. 2018 Jul 6;17(7):2282-2292. doi: 10.1021/acs.jproteome.7b00768. Epub 2018 Jun 6.

PMID:
29708756
26.

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.

Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T, Magdolen V, Batruch I, Diamandis EP.

J Proteomics. 2018 Jun 30;182:12-20. doi: 10.1016/j.jprot.2018.04.027. Epub 2018 Apr 22.

PMID:
29684683
27.

Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer.

Solassol J, Quantin X, Larrieux M, Senal R, Audran P, Grand D, Mangé A, Diamandis EP, Vendrell JA.

Clin Chem Lab Med. 2018 Aug 28;56(9):e243-e246. doi: 10.1515/cclm-2017-0967. No abstract available.

PMID:
29626410
28.

Benign and malignant scientific irreproducibility.

Fiala C, Diamandis EP.

Clin Biochem. 2018 May;55:1-2. doi: 10.1016/j.clinbiochem.2018.03.015. Epub 2018 Mar 31.

PMID:
29608889
29.

The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.

Di Meo A, Wang C, Cheng Y, Diamandis EP, Yousef GM.

Biol Chem. 2018 Sep 25;399(9):973-982. doi: 10.1515/hsz-2018-0112. Review.

PMID:
29604203
30.

Hubris and Sciences.

Diamandis EP, Bouras N.

F1000Res. 2018 Feb 1;7:133. doi: 10.12688/f1000research.13848.1. eCollection 2018.

31.

Young scientists and Clinical Biochemists need to develop superior negotiating skills.

Fiala C, Diamandis EP.

Clin Biochem. 2018 Apr;54:142. doi: 10.1016/j.clinbiochem.2018.02.016. Epub 2018 Mar 2. No abstract available.

PMID:
29505768
32.

Is it time to abandon the Nobel Prize?

Fiala C, Diamandis EP.

Clin Chem Lab Med. 2018 Jul 26;56(8):1196-1197. doi: 10.1515/cclm-2018-0027. No abstract available.

33.

A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.

Di Meo A, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM.

Oncotarget. 2017 Dec 8;9(2):2092-2104. doi: 10.18632/oncotarget.23162. eCollection 2018 Jan 5.

34.

Proteinases and their receptors in inflammatory arthritis: an overview.

Oikonomopoulou K, Diamandis EP, Hollenberg MD, Chandran V.

Nat Rev Rheumatol. 2018 Mar;14(3):170-180. doi: 10.1038/nrrheum.2018.17. Epub 2018 Feb 8. Review.

PMID:
29416136
35.

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

Patra K, Soosaipillai A, Sando SB, Lauridsen C, Berge G, Møller I, Grøntvedt GR, Bråthen G, Begcevic I, Moussaud S, Minthon L, Hansson O, Diamandis EP, White LR, Nielsen HM.

Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.

36.

Can circulating tumor DNA be used for direct and early stage cancer detection?

Diamandis EP, Fiala C.

F1000Res. 2017 Dec 13;6:2129. doi: 10.12688/f1000research.13440.1. eCollection 2017.

37.

Athletes beware before throwing towels to audiences.

Diamandis EP.

Clin Chem Lab Med. 2018 Feb 23;56(3):e82. doi: 10.1515/cclm-2017-1001. No abstract available.

PMID:
29232187
38.

Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.

Mahendran SM, Oikonomopoulou K, Diamandis EP, Chandran V.

Crit Rev Clin Lab Sci. 2017 Nov - Dec;54(7-8):495-505. doi: 10.1080/10408363.2017.1408561. Epub 2017 Dec 4. Review.

PMID:
29202618
39.

Make researchers revisit past publications to improve reproducibility.

Fiala C, Diamandis EP.

F1000Res. 2017 Sep 21;6:1717. doi: 10.12688/f1000research.12715.1. eCollection 2017.

40.

How to reduce scientific irreproducibility: the 5-year reflection.

Fiala C, Diamandis EP.

Clin Chem Lab Med. 2017 Oct 26;55(12):1845-1848. doi: 10.1515/cclm-2017-0759.

41.

Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.

Dimitrakopoulos L, Prassas I, Diamandis EP, Charames GS.

Crit Rev Clin Lab Sci. 2017 Sep;54(6):414-432. doi: 10.1080/10408363.2017.1384446. Epub 2017 Oct 12. Review.

PMID:
29025326
42.

Discovery of Antimicrobial Peptides in Cervical-Vaginal Fluid from Healthy Nonpregnant Women via an Integrated Proteome and Peptidome Analysis.

Muytjens CMJ, Yu Y, Diamandis EP.

Proteomics. 2017 Nov;17(21). doi: 10.1002/pmic.201600461. Epub 2017 Oct 20.

PMID:
28941238
43.

Rofa Nadofederal-The greatest tennis player that ever lived: A science fiction story depicting a future where biotechnology is unchecked.

Diamandis EP.

Clin Biochem. 2017 Nov;50(16-17):977-978. doi: 10.1016/j.clinbiochem.2017.08.016. Epub 2017 Aug 25. No abstract available.

PMID:
28847719
44.

Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women.

Eklund E, Diamandis EP, Muytjens C, Wheeler S, Mathew A, Stengelin M, Glezer E, Nikolenko G, Brown MD, Zheng Y, Hirschberg AL.

F1000Res. 2017 Jul 17;6:1131. doi: 10.12688/f1000research.11821.1. eCollection 2017.

45.

Circulating tumor DNA for personalized lung cancer monitoring.

Fiala C, Diamandis EP.

BMC Med. 2017 Aug 17;15(1):157. doi: 10.1186/s12916-017-0921-6.

46.

Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids.

Farkona S, Soosaipillai A, Filippou P, Korbakis D, Serra S, Rückert F, Diamandis EP, Blasutig IM.

Clin Biochem. 2017 Dec;50(18):1168-1174. doi: 10.1016/j.clinbiochem.2017.07.012. Epub 2017 Jul 23.

PMID:
28746862
47.

HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.

Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS.

Exp Mol Pathol. 2017 Aug;103(1):94-100. doi: 10.1016/j.yexmp.2017.07.002. Epub 2017 Jul 15.

PMID:
28716573
48.

Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids.

Korbakis D, Soosaipillai A, Diamandis EP.

Clin Chem Lab Med. 2017 Aug 28;55(9):1385-1396. doi: 10.1515/cclm-2017-0017.

PMID:
28672746
49.

Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.

Delaunay T, Deschamps L, Haddada M, Walker F, Soosaipillai A, Soualmia F, El Amri C, Diamandis EP, Brattsand M, Magdolen V, Darmoul D.

Mol Oncol. 2017 Oct;11(10):1330-1347. doi: 10.1002/1878-0261.12103. Epub 2017 Aug 11.

50.

The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges.

Fung AWS, Beriault D, Diamandis EP, Burnham CD, Dorman T, Downing M, Hayden J, Langford BJ.

Clin Chem. 2017 Sep;63(9):1436-1441. doi: 10.1373/clinchem.2017.272294. Epub 2017 Jun 20. No abstract available.

Supplemental Content

Loading ...
Support Center